Interestingly, scientists do not fully understand the precise neurochemical mechanisms by which Risperdal and other dopamine agonists act. The brain is an immensely complex organ, and it is incredibly hard to study, even with advanced modern imaging techniques. Part of the challenge has to do with the integrated nature of the brain. Just because a neuroscientist can identify certain brain regions as places that process language, sight or smell, for instance, does not mean that the scientist can predict how disruptions to those regions (or to the neurochemistry that regulates them) will translate into real world thoughts, actions and phenomena.

Drug effects can also be quite unpredictable from patient to patient. Certain pharmaceuticals can create a diverse constellation of effects – normalizing dopamine, for instance, in some patients, while disregulating levels of other neurotransmitters, hormones and enzymes in others.

Context matters. Patient history matters. Genetics matters.

Do not be misled into thinking that a drug like Risperdal has simple, clear, easily understood effects on the brain or on the body. The science is still relatively new and raw.

For insight into your Risperdal case, call the Davis & Crump team now at 800-277-0300 or email us at info@daviscrump.com.